Free Trial
NASDAQ:SRTS

Sensus Healthcare (SRTS) Stock Price, News & Analysis

Sensus Healthcare logo
$3.46 -1.89 (-35.33%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$3.44 -0.02 (-0.43%)
As of 08/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Sensus Healthcare Stock (NASDAQ:SRTS)

Key Stats

Today's Range
$3.10
$3.58
50-Day Range
$3.46
$5.65
52-Week Range
$3.10
$9.33
Volume
1.19 million shs
Average Volume
142,273 shs
Market Capitalization
$56.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.33
Consensus Rating
Buy

Company Overview

Sensus Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
28th Percentile Overall Score

SRTS MarketRank™: 

Sensus Healthcare scored higher than 28% of companies evaluated by MarketBeat, and ranked 741st out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Sensus Healthcare has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Sensus Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Sensus Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Sensus Healthcare are expected to decrease by -28.13% in the coming year, from $0.32 to $0.23 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Sensus Healthcare is -57.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Sensus Healthcare is -57.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Sensus Healthcare has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    5.97% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 5.56%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Sensus Healthcare does not currently pay a dividend.

  • Dividend Growth

    Sensus Healthcare does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.97% of the float of Sensus Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Sensus Healthcare has a short interest ratio ("days to cover") of 9.3.
  • Change versus previous month

    Short interest in Sensus Healthcare has recently decreased by 5.56%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Sensus Healthcare has a news sentiment score of -0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.38 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Sensus Healthcare this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for SRTS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Sensus Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.90% of the stock of Sensus Healthcare is held by insiders.

  • Percentage Held by Institutions

    Only 25.30% of the stock of Sensus Healthcare is held by institutions.

  • Read more about Sensus Healthcare's insider trading history.
Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

Sensus Healthcare, Inc. (SRTS) Q2 2025 Earnings Call Transcript
$100 Trillion “AI Metal” Found in American Ghost Town
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

SRTS Stock Analysis - Frequently Asked Questions

Sensus Healthcare's stock was trading at $6.92 at the beginning of 2025. Since then, SRTS shares have decreased by 50.0% and is now trading at $3.46.

Sensus Healthcare, Inc. (NASDAQ:SRTS) released its quarterly earnings results on Thursday, August, 7th. The company reported ($0.06) earnings per share for the quarter, missing analysts' consensus estimates of $0.01 by $0.07. The business earned $7.32 million during the quarter, compared to the consensus estimate of $9.30 million. Sensus Healthcare had a negative net margin of 2.26% and a negative trailing twelve-month return on equity of 1.56%.
Read the conference call transcript
.

Sensus Healthcare (SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

Top institutional investors of Sensus Healthcare include Kingstone Capital Partners Texas LLC (4.07%), Geode Capital Management LLC (0.94%), Sachetta LLC (0.78%) and Evernest Financial Advisors LLC (0.33%). Insiders that own company stock include Joseph C Sardano, Samuel O'rear, John Heinrich and Michael Sardano.
View institutional ownership trends
.

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sensus Healthcare investors own include NVIDIA (NVDA), Broadcom (AVGO), Meta Platforms (META), CrowdStrike (CRWD), EMCOR Group (EME), e.l.f. Beauty (ELF) and Arista Networks (ANET).

Company Calendar

Last Earnings
8/07/2025
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:SRTS
CIK
1494891
Employees
40
Year Founded
2010

Price Target and Rating

High Price Target
$13.00
Low Price Target
$10.00
Potential Upside/Downside
+237.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.10
Trailing P/E Ratio
34.60
Forward P/E Ratio
10.81
P/E Growth
N/A
Net Income
$6.65 million
Net Margins
4.56%
Pretax Margin
8.76%
Return on Equity
3.34%
Return on Assets
3.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
8.06
Quick Ratio
5.74

Sales & Book Value

Annual Sales
$41.81 million
Price / Sales
1.36
Cash Flow
$0.28 per share
Price / Cash Flow
12.34
Book Value
$3.41 per share
Price / Book
1.01

Miscellaneous

Outstanding Shares
16,440,000
Free Float
14,981,000
Market Cap
$56.88 million
Optionable
Optionable
Beta
1.34

Social Links

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:SRTS) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners